Editorial: Anakoinosis: An Innovative Anticancer Therapy Targeting the Aberrant Cancer Tissue Homeostasis
- PMID: 34690792
- PMCID: PMC8528999
- DOI: 10.3389/fphar.2021.779021
Editorial: Anakoinosis: An Innovative Anticancer Therapy Targeting the Aberrant Cancer Tissue Homeostasis
Keywords: DNA gels; Hodgkin’s lymphoma; acute lymphoblastic leukemia; anakoinosis; gold nanorods; graft versus host disease; non-small cell lung cancer; shear stress.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Comment on
- Editorial on the Research Topic Anakoinosis: An Innovative Anticancer Therapy Targeting the Aberrant Cancer Tissue Homeostasis
References
-
- Muqaku B., Eisinger M., Meier S. M., Tahir A., Pukrop T., Haferkamp S., et al. (2017): Multi-omics Analysis of Serum Samples Demonstrates Reprogramming of Organ Functions via Systemic Calcium Mobilization and Platelet Activation in Metastatic Melanoma. Mol. Cell Proteomics 16 (1), S. 86–99. 10.1074/mcp.M116.063313 - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources